---
title: "MDR rule 18: Tissues or cells of human or animal origin"
url: https://normiq.app/en/classification/mdr/rule-18
language: en
updated: 2026-11-15
---

# MDR rule 18: Tissues or cells of human or animal origin

MDR · Annex VIII, Section 7.5 · SPECIAL RULES

Updated on November 15, 2026

## Official text

All devices manufactured utilising tissues or cells of human or animal origin, or their derivatives, which are non-viable or rendered non-viable, are classified as class III, unless such devices are manufactured utilising tissues or cells of animal origin, or their derivatives, which are non-viable or rendered non-viable and are devices intended to come into contact with intact skin only.

MDR, Annex VIII, Section 7.5, consolidated version of July 19, 2026.

Short link: [normiq.app/en/mdr/annexe/viii/18](https://normiq.app/en/mdr/annexe/viii/18)

## In plain words

A device manufactured utilising non-viable, or rendered non-viable, tissues or cells of human or animal origin, or their derivatives, is in class III, unless the tissues or cells are of animal origin and the device is intended to come into contact with intact skin only: the rule then does not place it in class III.

Explanation written by Normiq; only the official text above is authoritative.

## Examples from the MDCG guidance

The guidance lists these examples under rule 18 (MDCG 2021-24 Rev.1). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 3.1).

### Class III

- Animal derived biological heart valves

  MDCG 2021-24 Rev.1, 4.2, Rule 18, p. 53

- Collagen dermal fillers

  MDCG 2021-24 Rev.1, 4.2, Rule 18, p. 53

## Classes and Normiq roadmaps

Rule 18 assigns: Class III. For each, the Normiq roadmap on every market where Annex VIII applies.

### Class III

- [European Union 15 phases · 68 steps · estimated duration 540 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iii)
- [Switzerland 16 phases · 77 steps · estimated duration 270 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iii)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 630 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iii)

## The same rule in Switzerland

> Devices shall be divided into classes I, IIa, IIb and III, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-MDR, taking account of the implementing acts of the European Commission listed in Annex 5a.

Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.

[Art. 15 MedDO](https://www.fedlex.admin.ch/eli/cc/2020/552/en#art_15)

The families of rules, the cross-cutting criteria, Rule 11 and common pitfalls are explained in the guide: [MDR classification: the 22 rules of Annex VIII explained](https://normiq.app/en/guides/classification-mdr-annexe-viii)

## Classify your device

The tool asks the questions of the 22 rules of the MDR, one at a time, and gives the indicative class with the rule and its text.

[Open the classification tool](https://normiq.app/en/classification#outil)

## Official sources

- [MDR, consolidated version of July 19, 2026 (02017R0745-20260719), EUR-Lex](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20260719)
- [MDCG 2021-24 Rev.1, “Guidance on classification of medical devices”, April 2026, p. 53](https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf)
